Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

The Alzheimer’s Association has awarded Longeveron LLC, a Miami-based biopharmaceutical company that develops cellular therapies for aging-related diseases, a $3 million grant to be applied to the company’s mesenchymal stem cell Alzheimer’s research.

Source link

Related posts

Teaching NeuroImages: Spinal cord herniation after cervical corpectomy


Editorial for adult CSF total protein: Higher upper reference limits should be considered worldwide. A web-based survey


Multiple foraminal compression in a child with sialidosis type 2


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy